538 related articles for article (PubMed ID: 15132837)
41. [A quantitative trabecular structural analysis using X-ray micro CT in ovariectomized rats].
Guo HY; Zhang LD; Zheng LM; Zhang H; Ren FZ
Guang Pu Xue Yu Guang Pu Fen Xi; 2009 Aug; 29(8):2276-80. PubMed ID: 19839357
[TBL] [Abstract][Full Text] [Related]
42. Simvastatin treatment partially prevents ovariectomy-induced bone loss while increasing cortical bone formation.
Oxlund H; Andreassen TT
Bone; 2004 Apr; 34(4):609-18. PubMed ID: 15050891
[TBL] [Abstract][Full Text] [Related]
43. Effect of combined teriparatide and monthly minodronic acid therapy on cancellous bone mass in ovariectomized rats: a bone histomorphometry study.
Iwamoto J; Seki A; Sato Y
Bone; 2014 Jul; 64():88-94. PubMed ID: 24727162
[TBL] [Abstract][Full Text] [Related]
44. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
[TBL] [Abstract][Full Text] [Related]
45. Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats.
Ke HZ; Qi H; Chidsey-Frink KL; Crawford DT; Thompson DD
J Bone Miner Res; 2001 Apr; 16(4):765-73. PubMed ID: 11316005
[TBL] [Abstract][Full Text] [Related]
46. [Effects of Dioscorea septemloba on the biomechanical and bone histomorphometric parameters of femur in the ovariectomized rats].
Xing GS; Lou JS; Yu SL; Wang ZB; Shi YJ
Zhong Yao Cai; 2008 Feb; 31(2):272-6. PubMed ID: 18619278
[TBL] [Abstract][Full Text] [Related]
47. Effects of the selective estrogen receptor modulator ospemifene on bone in rats.
Kangas L; Härkönen P; Väänänen K; Peng Z
Horm Metab Res; 2014 Jan; 46(1):27-35. PubMed ID: 24108389
[TBL] [Abstract][Full Text] [Related]
48. Effects of nicotine on bone and calciotropic hormones in aged ovariectomized rats.
Iwaniec UT; Haynatzki GR; Fung YK; Akhter MP; Haven MC; Cullen DM
J Musculoskelet Neuronal Interact; 2002 Sep; 2(5):469-78. PubMed ID: 15758416
[TBL] [Abstract][Full Text] [Related]
49. Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats.
Iwamoto J; Yeh JK; Schmidt A; Rowley E; Stanfield L; Takeda T; Sato M
Calcif Tissue Int; 2005 Aug; 77(2):119-26. PubMed ID: 16059775
[TBL] [Abstract][Full Text] [Related]
50. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of substance P signaling aggravates the bone loss in ovariectomy-induced osteoporosis.
Zheng XF; Zhao ED; He JY; Zhang YH; Jiang SD; Jiang LS
Prog Biophys Mol Biol; 2016 Nov; 122(2):112-121. PubMed ID: 27237582
[TBL] [Abstract][Full Text] [Related]
52. Comparative therapeutic effects of alendronate and alfacalcidol on cancellous and cortical bone mass and mechanical properties in ovariectomized osteopenic rats.
Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
J Nutr Sci Vitaminol (Tokyo); 2006 Feb; 52(1):1-8. PubMed ID: 16637224
[TBL] [Abstract][Full Text] [Related]
53. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
Iwaniec UT; Samnegård E; Cullen DM; Kimmel DB
Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618
[TBL] [Abstract][Full Text] [Related]
54. Treatment of osteoporotic ovariectomized rats with 24,25(OH)2D3.
Gal-Moscovici A; Gal M; Popovtzer MM
Eur J Clin Invest; 2005 Jun; 35(6):375-9. PubMed ID: 15948898
[TBL] [Abstract][Full Text] [Related]
55. Minodronic acid (ONO-5920/YM529) prevents decrease in bone mineral density and bone strength, and improves bone microarchitecture in ovariectomized cynomolgus monkeys.
Mori H; Tanaka M; Kayasuga R; Masuda T; Ochi Y; Yamada H; Kishikawa K; Ito M; Nakamura T
Bone; 2008 Nov; 43(5):840-8. PubMed ID: 18718565
[TBL] [Abstract][Full Text] [Related]
56. Advantages of raloxifene over alendronate or estrogen on nonreproductive and reproductive tissues in the long-term dosing of ovariectomized rats.
Sato M; Bryant HU; Iversen P; Helterbrand J; Smietana F; Bemis K; Higgs R; Turner CH; Owan I; Takano Y; Burr DB
J Pharmacol Exp Ther; 1996 Oct; 279(1):298-305. PubMed ID: 8859007
[TBL] [Abstract][Full Text] [Related]
57. Mice lacking the plasminogen activator inhibitor 1 are protected from trabecular bone loss induced by estrogen deficiency.
Daci E; Verstuyf A; Moermans K; Bouillon R; Carmeliet G
J Bone Miner Res; 2000 Aug; 15(8):1510-6. PubMed ID: 10934649
[TBL] [Abstract][Full Text] [Related]
58. The fixed herbal drug composition "Saikokaryukotsuboreito" prevents bone loss with an association of serum IL-6 reductions in ovariectomized mice model.
Hattori T; Fei W; Kizawa T; Nishida S; Yoshikawa H; Kishida Y
Phytomedicine; 2010 Mar; 17(3-4):170-7. PubMed ID: 20097049
[TBL] [Abstract][Full Text] [Related]
59. Skeletal effects of bazedoxifene paired with conjugated estrogens in ovariectomized rats.
Komm BS; Vlasseros F; Samadfam R; Chouinard L; Smith SY
Bone; 2011 Sep; 49(3):376-86. PubMed ID: 21658483
[TBL] [Abstract][Full Text] [Related]
60. Ovariectomy-induced hyperphagia does not modulate bone mineral density or bone strength in rats.
Jiang JM; Sacco SM; Ward WE
J Nutr; 2008 Nov; 138(11):2106-10. PubMed ID: 18936205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
